Navigation Links
Confluent Translations Takes Part in MAGI EAST 2013
Date:5/2/2013

Pittsburgh, PA (PRWEB) May 02, 2013

Confluent Translations, a full-service ISO Certified translation company, today announced that Business Development Manager Nancy Cardone was selected to help with two MAGI East sessions in Boston, MA from May 5-8, 2013.

Nancy will moderate the “Clinical Research Around the World” panel which will discuss regulatory issues, health systems, therapeutic areas, and subject recruiting and cultures in Jordan, Mexico, Poland, Russia, South Africa and the Ukraine. For “Innovations in Investigator and Subject Recruiting,” she will chair the discussions on analytics for site feasibility assessment and subject eligibility.

Confluent will also be exhibiting and sharing translation advice at our booth. MAGI, with over 90 individual workshops centered around quality, regulatory compliance, site operations and other clinical research-related topics, expects over 500 attendees.

Confluent Translations, LLC is an ISO 9001:2008 woman owned professional language translation services firm located in Pittsburgh, Pennsylvania. Founded in 1992, they also hold GSA contract # GS-10F-0098Y. For more information about Confluent, visit http://www.confluenttranslations.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10687285.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Idem Translations Achieves EN 15038:2006 Certification
2. Idem Translations Achieves ISO 13485:2003 Certification
3. Dr. Kevin T. Tanty Takes a Bold New Approach to the Cavity Epidemic
4. Neighborhood Smiles of La Crosse Takes a Bold New Approach to the Tooth Decay Epidemic
5. The Drugs for Neglected Diseases initiative (DNDi) takes the BBVA Foundation Frontiers of Knowledge Award in the Development Cooperation category
6. AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia
7. Discovery in synthetic biology takes us a step closer to new industrial revolution
8. Junior Varsity Naturals launches sweepstakes with Sweepstakes Ninja
9. Win $1000 in prizes from the Christmas MEGA Sweepstakes from Sweepstakes Ninja
10. Former Stryker CEO Takes Reins at sBioMed
11. Hawaii Tech Asia Takes Hawaii & US Entrepreneurs To China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):